Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care

Objective To examine long-term organ damage and safety following treatment with belimumab plus standard of care (SoC) in patients with systemic lupus erythematosus (SLE). Methods Pooled data were examined from two ongoing open-label studies that enrolled patients who completed BLISS-52 or BLISS-76....

Ausführliche Beschreibung